# Roivant Sciences Ltd.: Form DEF 14A, filed Jul 26, 2024

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: DEF 14A
- Filed: 2024-07-26
- Accepted by EDGAR: Jul 26, 2024, 16:59 ET
- Period: 2024-09-10
- Accession: 0001140361-24-034423
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000114036124034423/ny20026685x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000114036124034423/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000114036124034423/ny20026685x1_def14a.htm

Filed Jul 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-034423. Last ingested by Listed: Nov 9, 2026, 17:41 ET. No prices; not investment advice.